Home  >  Cancer Action Teams  >  Genitourinary Cancer Action Team

Genitourinary Cancer Action Team

The Genitourinary (GU) Cancer Action Team serves as a collaborative, multidisciplinary approach for assessing, planning, monitoring, coordinating and evaluating the delivery of cancer care services. The team currently meets once a year and is comprised of  multidisciplinary physicians and allied healthcare professionals, including urologists, medical oncologists, a radiation oncologist, surgeons, internists, a nutritionist, a clinical research nurse and a patient navigator.

The GU Cancer Action Team strives:

• to standardize consistent educational materials
• to create screening guidelines
• to develop treatment plans through tumor boards to be utilized as guidelines in the treatment and care management of GU cancers.

Initiatives developed by the GU Cancer Action Team have included prostate screening and treatment guidelines for GU cancers, including prostate, bladder, kidney, testicular and penile cancers, based on the National Comprehensive Cancer Network (NCCN) guidelines. Standardized pathology reports were also established.

In addition, the team is developing an Awareness and Screening Calendar including community speaking engagements, Continuing Medical Education (CME). Their collaborative initiatives are ongoing and focused upon every September, during National Prostate Cancer Awareness Month.

GU Cancer Action Team Physicians

Ayer Bala, M.D.
Buffi G. Boyd, M.D.
Michael D. Funderburk, M.D.
James C. Judy, M.D.
Stephen Michigan, M.D.
John A. Pablo, M.D.
Mark A. Taylor, M.D.
Jennifer Yannucci, M.D.
Howard A. Zaren, M.D., F.A.C.S.